Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular closure devices: the second decade.

Harold L Dauerman1, Robert J Applegate, David J Cohen

  • 1Division of Cardiology, University of Vermont College of Medicine, Burlington, Vermont 05401, USA. harold.dauerman@vtmednet.org

Journal of the American College of Cardiology
|October 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.

Circulation. Cardiovascular interventions·2019
Same author

Trends in isolated aortic valve replacement in the United States in the early phase of expansion of TAVR.

International journal of cardiology·2019
Same author

Integrating Quality of Life and Survival Outcomes in Cardiovascular Clinical Trials.

Circulation. Cardiovascular quality and outcomes·2019
Same author

Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention.

Circulation. Cardiovascular quality and outcomes·2019
Same author

Treatment of acrodermatitis continua of hallopeau with ixekizumab.

The Journal of dermatological treatment·2019
Same author

ST-segment elevation myocardial infarction.

Nature reviews. Disease primers·2019

Vascular closure devices (VCDs) offer improved patient comfort and faster recovery after heart procedures. Despite initial concerns about cost and complications, VCDs are showing promise in reducing vascular issues.

Area of Science:

  • Cardiovascular Medicine
  • Medical Devices
  • Interventional Cardiology

Background:

  • Vascular closure devices (VCDs) aim to enhance patient comfort and ambulation post-cardiac procedures using femoral arterial access.
  • VCDs have demonstrated effective hemostasis, yet their adoption remains limited due to cost and insufficient data on complication reduction compared to manual compression.

Purpose of the Study:

  • To review the current status and future challenges of VCD utilization in cardiovascular procedures.
  • To assess the evolving role of VCDs in improving patient outcomes and procedural efficiency.

Main Methods:

  • Review of clinical data and literature on vascular closure devices.
  • Analysis of adoption trends, cost-effectiveness, and complication rates associated with VCDs.

Related Experiment Videos

Main Results:

  • Recent data indicate improvements in VCD technology and decreasing complication rates.
  • VCD utilization may enhance the post-procedural care pathway after femoral artery access.

Conclusions:

  • Future research should focus on definitive randomized trials and evaluating VCDs in high-risk patient populations.
  • Development of more advanced and ideal closure devices is essential for broader adoption and improved patient care.